Clinical trial

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

NCT01672931

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Oocyte Measurement Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2012-09-01

PhaseN/A

Conditions

Infertilityunresolved

Obesityverified · MONDO: obesity disorder

Interventions

Oocyte MeasurementOTHER

Sponsors & collaborators

Hillel Yaffe Medical Centerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01672931 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.